Placebo effect in the acute treatment of migraine: subcutaneous placebos are better than oral placebos

[1]  J. Schoenen,et al.  [The combination of oral lysine-acetylsalicylate and metoclopramide compared with oral sumatriptan in the treatment of migraine attacks. A randomized, double-blind, placebo-controlled clinical trial]. , 1996, Ugeskrift for laeger.

[2]  M. Ferrari,et al.  Rizatriptan vs sumatriptan in the acute treatment of migraine. A placebo-controlled, dose-ranging study. Dutch/US Rizatriptan Study Group. , 1996, Archives of neurology.

[3]  R. Cady,et al.  Efficacy and tolerability of subcutaneous sumatriptan administered using the IMITREX STATdose System. , 1996, Clinical therapeutics.

[4]  R. Harden,et al.  The Placebo Effect in Acute Headache Management: Ketorolac, Meperidine, and Saline in the Emergency Department , 1996, Headache.

[5]  F. Benedetti.  The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia , 1996, Pain.

[6]  F. Facchinetti,et al.  The Efficacy and Safety of Subcutaneous Sumatriptan in the Acute Treatment of Menstrual Migraine , 1995 .

[7]  F. Benedetti,et al.  Potentiation of placebo analgesia by proglumide , 1995, The Lancet.

[8]  L. Fabbri,et al.  [Evaluation of the efficacy of oral sumatriptan in the management of migraine attacks. Clinical results]. , 1995, La Clinica terapeutica.

[9]  J. Schoenen,et al.  The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine , 1995, The Lancet.

[10]  P. Tfelt-Hansen,et al.  Introduction of a Novel Self-Injector for Sumatriptan. A Controlled Clinical Trial in General Practice , 1995, Cephalalgia : an international journal of headache.

[11]  B. Kirkhart,et al.  Oral sumatriptan is effective and well tolerated for the acute treatment of migraine: results of a multicenter study. , 1995, Neurology.

[12]  B. Jamerson,et al.  Oral sumatriptan for the long-term treatment of migraine: clinical findings. , 1995, Neurology.

[13]  N. Cutler,et al.  Oral sumatriptan for the acute treatment of migraine: evaluation of three dosage strengths. , 1995, Neurology.

[14]  B. Akpunonu,et al.  Subcutaneous sumatriptan for treatment of acute migraine in patients admitted to the emergency department: a multicenter study. , 1995, Annals of emergency medicine.

[15]  L. Fabbri,et al.  High Efficacy and Low Frequency of Headache Recurrence after Oral Sumatriptan , 1995, The Journal of international medical research.

[16]  J. Pearce.  The placebo enigma. , 1995, QJM : monthly journal of the Association of Physicians.

[17]  J. Kay,et al.  Sumatriptan in Acute Migraine Using a Novel Cartridge System Self‐Injector , 1994, Headache.

[18]  R A Deyo,et al.  The importance of placebo effects in pain treatment and research. , 1994, JAMA.

[19]  M. Solbach,et al.  Treatment of Menstruation-Associated Migraine Headache With Subcutaneous Sumatriptan , 1993, Obstetrics and gynecology.

[20]  J. Bouchet,et al.  Subcutaneous Sumatriptan in the Acute Treatment of Migraine in Patients Using Dihydroergotamine as Prophylaxis , 1993, Headache.

[21]  M. Bousser,et al.  Efficacy of subcutaneous sumatriptan in the acute treatment of early‐morning migraine: a placebo‐controlled trial , 1993, Journal of internal medicine.

[22]  J. Osterhaus,et al.  Efficacy of subcutaneous sumatriptan in repeated episodes of migraine , 1993, Neurology.

[23]  P. Parkin,et al.  Subcutaneous sumatriptan in acute treatment of migraine: a multicentre New Zealand trial. , 1993, The New Zealand medical journal.

[24]  J. Saper,et al.  Dose ranging efficacy and safety of subcutaneous sumatriptan in the acute treatment of migraine. US Sumatriptan Research Group. , 1992, Archives of neurology.

[25]  M. Ferrari,et al.  Treatment of Migraine Attacks with Subcutaneous Sumatriptan: First Placebo-Controlled Study , 1992, Cephalalgia : an international journal of headache.

[26]  C. Dahlöf,et al.  Sumatriptan Injection is Superior to Placebo in The Acute Treatment of Migraine With Regard to Both Efficacy and General Well-Being , 1992, Cephalalgia : an international journal of headache.

[27]  L. Findley,et al.  Sumatriptan in the Treatment of Acute Migraine With Aura , 1992, Cephalalgia : an international journal of headache.

[28]  J. Lance,et al.  Oral sumatriptan in acute migraine , 1991, The Lancet.

[29]  J. Rothrock,et al.  Treatment of acute migraine with subcutaneous sumatriptan. , 1991, JAMA.

[30]  F Mosteller,et al.  Some Statistical Methods for Combining Experimental Results , 1990, International Journal of Technology Assessment in Health Care.

[31]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[32]  R. Dubner,et al.  Placebo and naloxone can alter post-surgical pain by separate mechanisms , 1983, Nature.

[33]  A. Goldstein,et al.  Partial antagonism of placebo analgesia by naloxone , 1983, Pain.

[34]  S. Ross,et al.  Relationship of Perceptual Characteristics to Efficacy of Placebos , 1981, Psychological reports.

[35]  B. Vrhovac.  Placebo and its importance in medicine. , 1977, International journal of clinical pharmacology and biopharmacy.

[36]  Larry V. Hedges,et al.  Fixed-Effects Models , 2022, The SAGE Encyclopedia of Research Design.

[37]  A. Pilgrim.  Methodology of clinical trials of sumatriptan in migraine and cluster headache. , 1991, European neurology.

[38]  J. Lance,et al.  Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device. The Sumatriptan Auto-Injector Study Group. , 1991, European neurology.

[39]  Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society. , 1988, Cephalalgia : an international journal of headache.

[40]  J. Levine,et al.  Influence of the method of drug administration on analgesic response , 1984, Nature.